Advertisement
Singapore markets closed
  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     
  • Nikkei

    38,946.93
    -122.75 (-0.31%)
     
  • Hang Seng

    19,220.62
    -415.60 (-2.12%)
     
  • FTSE 100

    8,416.45
    -7.75 (-0.09%)
     
  • Bitcoin USD

    69,756.86
    +1,251.89 (+1.83%)
     
  • CMC Crypto 200

    1,518.41
    +29.87 (+2.01%)
     
  • S&P 500

    5,307.87
    -0.26 (-0.00%)
     
  • Dow

    39,804.17
    -2.60 (-0.01%)
     
  • Nasdaq

    16,784.50
    -10.37 (-0.06%)
     
  • Gold

    2,424.00
    -14.50 (-0.59%)
     
  • Crude Oil

    79.21
    -0.59 (-0.74%)
     
  • 10-Yr Bond

    4.4060
    -0.0310 (-0.70%)
     
  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     
  • Jakarta Composite Index

    7,186.04
    -80.65 (-1.11%)
     
  • PSE Index

    6,633.66
    -49.12 (-0.74%)
     

Raffles Medical CEO Loo acquires 100,000 shares at $1.03 each

After the purchase, Loo’s direct stake in Raffles Medical has increased to 11.573% from 11.568% previously.

Dr Loo Choon Yong, the CEO and a substantial shareholder of Raffles Medical Group BSL, has acquired 100,000 units in the company for $103,000 or $1.03 each.

The shares were sold via market transaction on March 19.

After the purchase, Loo’s direct stake in Raffles Medical has increased to 11.573% from 11.568% previously.

In addition, Loo has a deemed interest in another 783.8 million shares, giving him a total interest of 998.75 million shares, or 53.782%.

Units in Raffles Medical closed 1 cent higher or 0.97% up at $1.04 on March 20.

ADVERTISEMENT

See Also: